Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
出版年份 2019 全文链接
标题
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
作者
关键词
-
出版物
Journal of Neuroinflammation
Volume 16, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-10-11
DOI
10.1186/s12974-019-1567-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants
- (2018) Pratishtha Chatterjee et al. JOURNAL OF ALZHEIMERS DISEASE
- High performance plasma amyloid-β biomarkers for Alzheimer’s disease
- (2018) Akinori Nakamura et al. NATURE
- Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study
- (2018) Pratishtha Chatterjee et al. Scientific Reports
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load
- (2017) K Goozee et al. MOLECULAR PSYCHIATRY
- Kynurenine pathway metabolism and neuroinflammatory disease
- (2017) Nady Braidy et al. Neural Regeneration Research
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
- (2017) Lenka Novakova et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases
- (2017) Michael D. Lovelace et al. NEUROPHARMACOLOGY
- Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
- (2017) Chai K. Lim et al. Scientific Reports
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease
- (2017) Kathryn Goozee et al. Scientific Reports
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Neurofilament light chain: a biomarker for genetic frontotemporal dementia
- (2016) Lieke H. Meeter et al. Annals of Clinical and Translational Neurology
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Alzheimer’s Disease, Astrocytes and Kynurenines
- (2015) Livia Dezsi et al. Current Alzheimer Research
- Comparison of MR-less PiB SUVR quantification methods
- (2015) Pierrick Bourgeat et al. NEUROBIOLOGY OF AGING
- Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
- (2015) David C. Bäckström et al. JAMA Neurology
- Expression of the Kynurenine Pathway in Human Peripheral Blood Mononuclear Cells: Implications for Inflammatory and Neurodegenerative Disease
- (2015) Simon P. Jones et al. PLoS One
- Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis
- (2015) Roberta Mancuso et al. PLoS One
- Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
- (2014) J. Kuhle et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- MR-Less Surface-Based Amyloid Assessment Based on 11C PiB PET
- (2014) Luping Zhou et al. PLoS One
- Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration
- (2013) Carole S. Scherling et al. ANNALS OF NEUROLOGY
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
- (2013) Johanna Gaiottino et al. PLoS One
- Kynurenines in the mammalian brain: when physiology meets pathology
- (2012) Robert Schwarcz et al. NATURE REVIEWS NEUROSCIENCE
- CSF-Biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma
- (2012) Sanna Neselius et al. PLoS One
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
- (2011) Daniel Zwilling et al. CELL
- Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample
- (2011) H. C. Rossetti et al. NEUROLOGY
- Kynurenine and its metabolites in Alzheimer's disease patients
- (2010) E Gulaj et al. Advances in Medical Sciences
- Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats
- (2010) Paula Pierozan et al. EXPERIMENTAL NEUROLOGY
- Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease
- (2010) David J. Bonda et al. REDOX REPORT
- Does neuroinflammation fan the flame in neurodegenerative diseases?
- (2009) Tamy C Frank-Cannon et al. Molecular Neurodegeneration
- The Kynurenine Pathway and Inflammation in Amyotrophic Lateral Sclerosis
- (2009) Yiquan Chen et al. NEUROTOXICITY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started